Work

Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-151016

Authors: James R. Berenson, Daisy Martinez, Tahmineh Safaie, Noemi Silagan, Jennifer To, Tanya M. Spektor, Eli Forouzan, Regina Swift, Benjamin Eades, Shahrooz Eshaghian, Gary Schwartz, Ralph V. Boccia, Honghao H Yang, Mehdi M. Moezi, Stephen Lim, Robert Vescio

Institutions: Oncotherapeutics (United States), Institute for Myeloma & Bone Cancer Research, West Michigan Cancer Center, Center for Cancers and Blood Disorders, Cedars-Sinai Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4200127932

Cites:

Cited by: 1

Related to: 10